THE INFLUENCE OF LEPTIN ON THE DEVELOPMENT OF IMMUNOLOGICAL DISORDERS IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND HYPOTHYROIDISM

  • Tatiana Yuzvenko Ukrainian Scientifically and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organsand Tissues, Ministry of Public Health of Ukraine
  • Vladimir Pankiv Ukrainian Scientifically and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organsand Tissues, Ministry of Public Health of Ukraine
Keywords: diabetes mellitus type 2, obesity, autoimmune diseases, hypothyroidism, leptin, interleukin-6

Abstract

The work deals with the determination of leptin and IL-6 influence on the development of immune disorders in patients with DM type 2 with hypothyroidism. There were examined 34 patients with diabetes mellitus type 2 and hypothyroidism and 27 patients with the primary hypothyroidism without DM. It was revealed that obesity is characterized with an increase of leptin and IL-6 levels that, in its turn, condition the development of system inflammation of the low intensity and result in the increase of risk of autoimmune changes. In patients with DM type 2 in combination with hypothyroidism on the background of obesity the indices of leptin, IL-6, CD4+, CD8+ and IRI reliably differed from the ones in the group of patients without obesity that testifies to the negative influence of obesity on the development of autoimmune immunological disorders in patients with DM type 2. There were established the correlations between BMI and leptin and IL-6 CD4+, CD8+, ІRI indices in patients with DM type 2 in combination with hypothyroidism.

Downloads

Download data is not yet available.

Author Biographies

Tatiana Yuzvenko, Ukrainian Scientifically and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organsand Tissues, Ministry of Public Health of Ukraine

Department of prevention, treatment of diabetes mellitus, and its complications

Vladimir Pankiv, Ukrainian Scientifically and Practical Centre of Endocrine Surgery, Transplantation of Endocrine Organsand Tissues, Ministry of Public Health of Ukraine

Department of prevention, treatment of diabetes mellitus, and its complications

References

Garber, J., Cobin, R., Gharib, H., Hennessey, J., Klein, I., Mechanick, J. et. al (2012). Clinical Practice Guidelines for Hypothyroidism in Adults: Cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocrine Practice, 18 (6), 988–1028. doi: 10.4158/ep12280.gl

Singh, G. M., Danaei, G., Farzadfar, F., Stevens, G. A., Woodward, M., Wormser, D. et. al (2013). The Age-Specific Quantitative Effects of Metabolic Risk Factors on Cardiovascular Diseases and Diabetes: A Pooled Analysis. PLoS ONE, 8 (7), e65174. doi: 10.1371/journal.pone.0065174

Hennessey, J. V., Espaillat, R. (2015). Diagnosis and Management of Subclinical Hypothyroidism in Elderly Adults: A Review of the Literature. Journal of the American Geriatrics Society, 63 (8), 1663–1673. doi: 10.1111/jgs.13532

Berrington de Gonzalez, A., Hartge, P., Cerhan, J. R., Flint, A. J., Hannan, L., MacInnis, R. J. et. al (2010). Body-Mass Index and Mortality among 1.46 Million White Adults. New England Journal of Medicine, 363(23), 2211–2219. doi: 10.1056/nejmoa1000367

Johnson, J. L. (2006). Diabetes Control in Thyroid Disease. Diabetes Spectrum, 19 (3), 148–153. doi: 10.2337/diaspect.19.3.148

Man’kovskij, B. N. (2014). Rasprostranennost’ nevyjavlennogo saharnogo diabeta 2 tipa i prediabeta v Ukraine: rezul’taty jepidemiologicheskogo issledovanija «DIAPAZON». Diabet. Ozhirenie. Metabolicheskij sindrom, 3 (5), 70–75.

Global status report on noncommunicable diseases 2014 (2014). WHO. Geneva: World Health Organization, 298.

Zheng, W., McLerran, D. F., Rolland, B., Zhang, X., Inoue, M., Matsuo, K. et. al (2011). Association between Body-Mass Index and Risk of Death in More Than 1 Million Asians. New England Journal of Medicine, 364 (8), 719–729. doi: 10.1056/nejmoa1010679

The Emerging Risk Factors Collaboration (2011). Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. The Lancet, 377 (9771), 1085–1095. doi: 10.1016/s0140-6736(11)60105-0

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1•8 million participants (2014). The Lancet, 383 (9921), 970–983. doi: 10.1016/s0140-6736(13)61836-x

Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C. et. al (2014). Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet, 384 (9945), 766–781. doi: 10.1016/s0140-6736(14)60460-8

Stevens, G. A., Singh, G. M., Lu, Y., Danaei, G., Lin, J. K., Finucane, M. M. et. al (2012). National, regional, and global trends in adult overweight and obesity prevalences. Population Health Metrics, 10 (1), 22. doi: 10.1186/1478-7954-10-22

Kitahara, C. M., Flint, A. J., Berrington de Gonzalez, A., Bernstein, L., Brotzman, M., MacInnis, R. J. et. al (2014). Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies. PLoS Medicine, 11 (7), e1001673. doi: 10.1371/journal.pmed.1001673

Han, Z., Mulla, S., Beyene, J., Liao, G., McDonald, S. D. (2010). Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta-analyses. International Journal of Epidemiology, 40 (1), 65–101. doi: 10.1093/ije/dyq195

Danaei, G., Finucane, M. M., Lin, J. K., Singh, G. M., Paciorek, C. J., Cowan, M. J. et. al (2011). National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5•4 million participants. The Lancet, 377 (9765), 568–577. doi: 10.1016/s0140-6736(10)62036-3

Danaei, G., Singh, G. M., Paciorek, C. J., Lin, J. K., Cowan, M. J., Finucane, M. M. et. al (2013). The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with National Income, Urbanization, and Western Diet in 1980 and 2008. Circulation, 127 (14), 1493–1502. doi: 10.1161/circulationaha.113.001470

Ezzati, M., Riboli, E. (2013). Behavioral and Dietary Risk Factors for Noncommunicable Diseases. New England Journal of Medicine, 369(10), 954–964. doi:10.1056/nejmra1203528

Huxley, R., Mendis, S., Zheleznyakov, E., Reddy, S., Chan, J. (2009). Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk – a review of the literature. European Journal of Clinical Nutrition, 64 (1), 16–22. doi: 10.1038/ejcn.2009.68

Pednekar, M. S., Hakama, M., Hebert, J. R., Gupta, P. C. (2008). Association of body mass index with all-cause and cause-specific mortality: findings from a prospective cohort study in Mumbai (Bombay), India. International Journal of Epidemiology, 37 (3), 524–535. doi: 10.1093/ije/dyn001

Di Cesare, M., Bennett, J. E., Best, N., Stevens, G. A., Danaei, G., Ezzati, M. (2013). The contributions of risk factor trends to cardiometabolic mortality decline in 26 industrialized countries. International Journal of Epidemiology, 42 (3), 838–848. doi: 10.1093/ije/dyt063

Ezzati, M., Riboli, E. (2012). Can Noncommunicable Diseases Be Prevented? Lessons from Studies of Populations and Individuals. Science, 337 (6101), 1482–1487. doi: 10.1126/science.1227001


👁 383
⬇ 347
Published
2016-06-10
How to Cite
Yuzvenko, T., & Pankiv, V. (2016). THE INFLUENCE OF LEPTIN ON THE DEVELOPMENT OF IMMUNOLOGICAL DISORDERS IN PATIENTS WITH DIABETES MELLITUS TYPE 2 AND HYPOTHYROIDISM. EUREKA: Health Sciences, (3), 45-50. https://doi.org/10.21303/2504-5679.2016.00099
Section
Medicine and Dentistry